We have completed our migration to a new platform and are pleased to introduce the updated site. What to expect: If you have an existing login, please RESET YOUR ...
Clinical Trials Arena on MSN
IDEAYA reports top line data from Phase II/III trial of darovasertib combo
The trial enrolled 210 patients in the darovasertib combination arm and 103 in the ICT arm.
New Drug Application (NDA) based on data in TKI pre-treated patients from the global ALKOVE-1 Phase 1/2 clinical trial CAMBRIDGE, Mass., April 7, 2026 /PRNewswire/ ...
FDA feedback enables Corbus to proceed with proposed registrational study design and endpoints to support potential accelerated approval in ...
April 8, 2026 - Inventiva (Euronext Paris and NASDAQ: IVA) (the 'Company”), a clinical-stage biopharmaceutical company ...
The National Biosafety Management Agency (NBMA) has alerted the public of recent developments concerning the registration ...
The National Biosafety Management Agency (NBMA) has identified irregularities in the approval of four genetically ...
The FDA and Corbus Pharmaceuticals Holdings, Inc., have agreed on second-line registrational study designs evaluating CRB-701 ...
MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
Alignment with the FDA across proposed study parameters of RESTORE, a 16-week registrational study evaluating NVG-291 in chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results